ESR1 Gene Mutation
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB06374 | Elacestrant | An estrogen receptor antagonist used to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00675 | Tamoxifen | 0 | Recruiting | 1 |
| DB01234 | Dexamethasone | 3 | Not Yet Recruiting | 1 |
| DB06374 | Elacestrant | 3 | Not Yet Recruiting | 1 |
| DB01175 | Escitalopram | 3 | Not Yet Recruiting | 1 |
| DB00783 | Estradiol | 3 | Not Yet Recruiting | 1 |
| DB01590 | Everolimus | 3 | Not Yet Recruiting | 1 |
| DB14741 | Luteinizing hormone | 3 | Not Yet Recruiting | 1 |